Simple blood test could transform cancer treatment decisions
NCT ID NCT06367751
First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 28 times
Summary
This study looks at whether a simple blood test (liquid biopsy) can be used during routine care for people with advanced solid tumors. Researchers will check how often the test finds cancer DNA and whether it helps doctors choose better treatments. About 159 patients will participate, and their results will be compared to patients who did not get the test.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Medical Oncology, University Hospital Basel
Basel, 4031, Switzerland
Conditions
Explore the condition pages connected to this study.